Off-label prescribing in pain medicine practice
FPM has published a new guidance document to inform the professional practice of FPM fellows and trainees.
The ethical and legal framework surrounding off-label prescribing in pain medicine has been a topic of discussion since the establishment of the Faculty of Pain Medicine (FPM). This complex issue arises from the need to balance patient care, professional judgment, and adherence to regulatory and ethical standards.
The faculty resolved to adopt the seven guiding principles for off label prescribing articulated by the Council of Australian Therapeutic Advisory Groups (CATAG) in their 2013 document entitled Rethinking medicines decision-making in Australian Hospitals; Guiding principles for the quality use of off label medicines.
A guidance document has been formulated to articulate the consensus views of the faculty leadership as well as reflect legal and ethical principles to inform the professional practice of FPM fellows and trainees.
For further information, please contact the faculty.
You might also be interested in...
In June, the FPM Dean wrote to the Federal Health Minister Mark Butler with five key recommendations aimed at addressing critical gaps in the pain care system.
New this month: ACHS QI Awards; ACSQHC NSQHS 3rd ed.; TGA advisory committee vacancies; webAIRS ANZCA ASM media release.
Your monthly digest of professional document developments. In summary, there are 52 prof docs and joint statements in total, including 17 prof docs and joint statements under development/review, stakeholder consultation or pilot. In addition, there are 6 pain medicine (PM) prof docs and 5 under development/review.